Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lexicon Pharmaceuticals Has Enrolled The First Patient In PROGRESS Phase 2B Trial With An Open-label Extension In Patients With Diabetic Peripheral Neuropathic Pain Studying LX9211

Author: Benzinga Newsdesk | November 30, 2023 08:33am

Posted In: LXRX